Stockscreener 앱 받기
31.49
0.29%
0.09
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Insider Sell: Mike Mensinger Sells 2,200 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Insider Sell: Mike Mensinger Sells 7,800 Shares of Beta Bionics Inc (BBNX) - GuruFocus
Mike Mensinger Sells 7,800 Shares of Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 20,000 Shares of Stock - MarketBeat
Beta Bionics CFO Sells 20,000 Shares - TradingView — Track All Markets
Bank of America Forecasts Strong Price Appreciation for Beta Bionics (NASDAQ:BBNX) Stock - MarketBeat
FOMO Trade: How Beta Bionics Inc stock reacts to inflationary pressuresWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Beta Bionics Reports Strong Q3 Growth Amid Challenges - MSN
Fourteen new option listings on November 12th - MSN
Artificial Pancreas System Market is set for steady growth to US$ - openPR.com
Beta Bionics (NASDAQ:BBNX) Trading Up 8.7%Should You Buy? - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Market Review: How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Opening Moves & Verified Momentum Stock Ideas - Улправда
Why Beta Bionics Inc. stock is a must watch in 20252025 Price Action Summary & Low Risk High Win Rate Picks - Улправда
Why Beta Bionics Inc. stock is a value investor pickDollar Strength & Advanced Technical Analysis Signals - ulpravda.ru
Why Beta Bionics Inc. stock is rated strong buyMarket Growth Summary & Intraday High Probability Setup Alerts - DonanımHaber
Will Beta Bionics Inc. stock attract more institutional investorsTrade Entry Report & Weekly High Conviction Trade Ideas - DonanımHaber
How Beta Bionics Inc. stock performs during Fed tightening cyclesJuly 2025 Volume & Safe Capital Growth Stock Tips - Улправда
Truist Securities Maintains Beta Bionics (BBNX) Buy Recommendation - Nasdaq
Is Beta Bionics (BBNX) Overvalued After Its Recent Share Price Momentum? - Yahoo Finance
Beta Bionics (NASDAQ:BBNX) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat
Truist Securities Adjusts Price Target on Beta Bionics to $37 From $32, Maintains Buy Rating - marketscreener.com
Beta Bionics (NASDAQ:BBNX) Given New $37.00 Price Target at Truist Financial - MarketBeat
Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN
Beta Bionics Earnings Notes - Trefis
Beta Bionics stock rating reiterated at Buy by Stifel - Investing.com Australia
Beta Bionics: It Has Been An Interesting Year (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics, Inc. $BBNX Shares Purchased by Walleye Capital LLC - MarketBeat
BBNX FinancialsIncome Statement - Quiver Quantitative
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 - The Manila Times
Divisadero Street Capital Management LP Purchases New Shares in Beta Bionics, Inc. $BBNX - MarketBeat
This Beta Bionics Insider Increased Their Holding By 130% Last Year - simplywall.st
Insider Selling: Beta Bionics (NASDAQ:BBNX) CFO Sells 1,427 Shares of Stock - MarketBeat
Feider Stephen (Beta Bionics) sells $41,862 in shares By Investing.com - Investing.com Canada
Top Executives at Beta Bionics, Inc. Cash Out on Stock Sales - TipRanks
Mensinger, Beta Bionics CPO, sells $31k in BBNX stock By Investing.com - Investing.com Nigeria
Feider Stephen (Beta Bionics) sells $41,862 in shares - Investing.com
Beta Bionics Executives Sell Shares for Tax Obligations - TradingView — Track All Markets
Officer Mensinger Files To Sell 1,063 Of Beta Bionics Inc [BBNX] - TradingView — Track All Markets
Mensinger, Beta Bionics CPO, sells $31k in BBNX stock - Investing.com
With Beta Bionics Stock Sliding, Have You Assessed The Risk? - Trefis
Insider Sell Alert: Adam Lezack Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta Bionics Executives Sell Shares - TradingView — Track All Markets
Midday Stock Roundup: Ingram Micro Falls - Orange County Business Journal
Beta Bionics (BBNX) Stock Analysis Report | Financials & Insights - Benzinga
Tech Watch: The Latest in Diabetes Tech News - Making Sense of Diabetes
BBNX Crosses Above Average Analyst Target - Nasdaq
Corporate – Shares – Settlement - Massachusetts Lawyers Weekly
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year HighHere's Why - MarketBeat
Beta Bionics, Inc. (NASDAQ:BBNX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Technical Analysis of Beta Bionics, Inc. (NASDAQ:BBNX) - TradingView
1.64%
0.32%
자본화:
|
볼륨(24시간):